Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees.

This report provides an update on key primary care prescribing trends in the North of England with respect to polypharmacy, in order to support primary care teams in identifying key groups who may benefit from a structured medicines review.

This publication is part of our Strategic Support and Planning contract. To gain access please email us at